TB Alternative Assets Ltd. Makes New Investment in Docusign Inc. $DOCU

TB Alternative Assets Ltd. purchased a new stake in Docusign Inc. (NASDAQ:DOCU) during the 3rd quarter, Holdings Channel reports. The firm purchased 7,866 shares of the company’s stock, valued at approximately $528,000. Docusign makes up about 0.1% of TB Alternative Assets Ltd.’s portfolio, making the stock its 29th biggest holding.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tred Avon Family Wealth LLC boosted its stake in shares of Docusign by 3.6% during the 1st quarter. Tred Avon Family Wealth LLC now owns 6,176 shares of the company’s stock worth $293,000 after buying an additional 215 shares during the last quarter. Riversedge Advisors LLC grew its holdings in shares of Docusign by 4.5% in the 3rd quarter. Riversedge Advisors LLC now owns 5,182 shares of the company’s stock valued at $348,000 after acquiring an additional 225 shares in the last quarter. First Citizens Bank & Trust Co. grew its holdings in shares of Docusign by 2.1% in the 1st quarter. First Citizens Bank & Trust Co. now owns 11,745 shares of the company’s stock valued at $557,000 after acquiring an additional 239 shares in the last quarter. Integrated Wealth Concepts LLC increased its position in shares of Docusign by 2.0% in the second quarter. Integrated Wealth Concepts LLC now owns 14,359 shares of the company’s stock valued at $638,000 after acquiring an additional 277 shares during the last quarter. Finally, OMERS ADMINISTRATION Corp increased its position in shares of Docusign by 3.4% in the first quarter. OMERS ADMINISTRATION Corp now owns 8,878 shares of the company’s stock valued at $421,000 after acquiring an additional 296 shares during the last quarter. 77.64% of the stock is owned by institutional investors.

Docusign Price Performance

Shares of DOCU stock opened at $77.52 on Friday. The company has a fifty day moving average price of $66.37 and a two-hundred day moving average price of $54.57. Docusign Inc. has a one year low of $40.16 and a one year high of $77.60. The stock has a market cap of $14.49 billion, a P/E ratio of 44.78, a P/E/G ratio of 2.78 and a beta of 0.86.

Docusign (NASDAQ:DOCU) last released its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.07. The company had revenue of $875.75 million for the quarter, compared to analyst estimates of $867.22 million. Docusign had a net margin of 9.82% and a return on equity of 18.29%. Docusign’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.30 EPS. As a group, equities research analysts anticipate that Docusign Inc. will post 2.14 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

DOCU has been the topic of several analyst reports. BTIG Research upped their target price on Docusign from $60.00 to $75.00 and gave the stock a “buy” rating in a report on Wednesday, September 2nd. Robert W. Baird raised their price target on Docusign from $55.00 to $72.00 and gave the company a “neutral” rating in a research note on Friday, September 4th. Wall Street Zen lowered Docusign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 2nd. Needham & Company LLC reiterated a “hold” rating on shares of Docusign in a research note on Friday, September 4th. Finally, Weiss Ratings upgraded Docusign from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Docusign has a consensus rating of “Hold” and a consensus price target of $67.33.

Insiders Place Their Bets

In other Docusign news, insider James P. Shaughnessy sold 12,000 shares of the company’s stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $68.80, for a total value of $825,600.00. Following the sale, the insider owned 50,591 shares in the company, valued at $3,480,660.80. This represents a 19.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robert Chatwani sold 14,676 shares of the company’s stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $69.41, for a total value of $1,018,661.16. Following the completion of the sale, the insider owned 75,928 shares in the company, valued at $5,270,162.48. This represents a 16.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 165,868 shares of company stock worth $11,121,890 in the last three months. Insiders own 0.59% of the company’s stock.

Key Stories Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Deeper Salesforce integration supports growth. Embedding DocuSign’s agreement tools directly into Salesforce’s ecosystem may make the platform more useful to sales teams and connect electronic agreements with AI-driven business processes. Why DocuSign Is Up After Deeper AI Integration Into Salesforce’s Agentforce Ecosystem
• Positive Sentiment: AI and IAM expansion are improving the investment narrative. Recent coverage highlights DocuSign’s strategy of embedding AI agreement tools across everyday workflows, while analysts point to growing IAM adoption and strong cash flow as supports for the company’s longer-term outlook. Why You Should Hold DOCU Stock
• Positive Sentiment: Strong momentum is attracting investor attention. DOCU recently reached a new 52-week high, and the stock has posted substantial gains over the past several months. Zacks also identified it as a heavily watched and strong-momentum stock, increasing near-term trading interest. DocuSign Breaks to a Fresh 52-Week High
• Neutral Sentiment: DocuSign participated in a $5.2 billion-valued financing for AI identity and fraud-prevention company Socure. The investment may provide strategic exposure to an adjacent technology market, but its direct financial effect on DocuSign is unclear. Socure Q3 2026 Results
• Negative Sentiment: Valuation is a key risk. With DOCU trading near its 52-week high, some coverage argues the shares could already be above fair value. A reported average analyst target of $71 is below the recent trading level, while competition and cloud-migration costs could pressure margins. Zacks Cites $71 Average Target for DocuSign Stock

Docusign Profile

DocuSign, Inc (NASDAQ:DOCU) provides cloud-based software for electronically signing, managing and automating agreements. Its platform enables individuals and organizations to prepare, send, sign, track and store documents digitally, helping replace paper-based contracting processes.

The company’s offerings include electronic signature tools, contract lifecycle management, identity verification and authentication services, document generation, agreement analytics and related workflow automation capabilities.